Candel Therapeutics Inc (CADL)

Other Income/Expenses (Net)

-$12.16M

Quarterly · Period ending: · USD

CADL logo

CADL Other Income/Expenses (Net)

Latest reported-$12.16M
CADL Quarterly Other Income/Expenses (Net) ($546.00K → -$12.16M)
High-resolution chart · PNG

CADL other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Candel Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-12,159,000
7,422,999
-13,744,000
1,938,000
6,381,000
15,509,000
-5,932,000
-1,889,000
-13,666,000
-319,000
-777,000
426,000
-35,000
838,000
3,018,000
193,000
4,604,000
8,112,000
9,336,000
-8,133,000
-11,779,000
179,000
-4,353,000
195,000
-257,000
546,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.